{"title":"Smoking and Smoking Relapse in Postpartum: A Systematic Review and Meta-analysis","authors":"S. Amiri, S. Saadat","doi":"10.1097/ADT.0000000000000282","DOIUrl":null,"url":null,"abstract":"Objectives: Smoking is a well-known factor in the negative health outcomes worldwide. This study aims to determine the smoking prevalence and relapse in women in the postpartum period based on the meta-analysis method. Methods: The steps provided by Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) were followed. According to keywords extracted by authors, 3 sources were searched until April 2020. To analyze the prevalence of smoking and relapse, the size of the sample and the event were calculated for eligible studies, and then the prevalence was calculated. Heterogeneity for all analyses and subgroups was investigated. Result: Forty articles were eligible for evaluation of the prevalence of smoking and smoking relapse in the postpartum period. The pooled prevalence of smoking/smoking relapse was 30%, with a confidence interval (CI) of 26%-34% and I 2=99.5%. The prevalence of smoking was 19% (CI=15%-22%, I 2=98.86%) and the prevalence of smoking relapse was 46% (CI=39%-54%, I 2=98.86%). The prevalence of 6-month postpartum smoking/smoking relapse was 29% (CI=23%-34%, I 2=99.42%). The prevalence of smoking/smoking relapse between 6 and 18 months was 31% (CI=24%-39%, I 2=99.51%). Discussion: Due to the role of smoking in disease and predisposing individuals to various diseases, and the prevalence of smoking and relapse in the postpartum period, it is necessary to develop prevention and awareness programs in this respect.","PeriodicalId":44600,"journal":{"name":"Addictive Disorders & Their Treatment","volume":null,"pages":null},"PeriodicalIF":1.1000,"publicationDate":"2021-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Addictive Disorders & Their Treatment","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/ADT.0000000000000282","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 1
Abstract
Objectives: Smoking is a well-known factor in the negative health outcomes worldwide. This study aims to determine the smoking prevalence and relapse in women in the postpartum period based on the meta-analysis method. Methods: The steps provided by Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) were followed. According to keywords extracted by authors, 3 sources were searched until April 2020. To analyze the prevalence of smoking and relapse, the size of the sample and the event were calculated for eligible studies, and then the prevalence was calculated. Heterogeneity for all analyses and subgroups was investigated. Result: Forty articles were eligible for evaluation of the prevalence of smoking and smoking relapse in the postpartum period. The pooled prevalence of smoking/smoking relapse was 30%, with a confidence interval (CI) of 26%-34% and I 2=99.5%. The prevalence of smoking was 19% (CI=15%-22%, I 2=98.86%) and the prevalence of smoking relapse was 46% (CI=39%-54%, I 2=98.86%). The prevalence of 6-month postpartum smoking/smoking relapse was 29% (CI=23%-34%, I 2=99.42%). The prevalence of smoking/smoking relapse between 6 and 18 months was 31% (CI=24%-39%, I 2=99.51%). Discussion: Due to the role of smoking in disease and predisposing individuals to various diseases, and the prevalence of smoking and relapse in the postpartum period, it is necessary to develop prevention and awareness programs in this respect.
期刊介绍:
Addictive Disorders & Their Treatment is a quarterly international journal devoted to practical clinical research and treatment issues related to the misuses of alcohol and licit and illicit drugs and the study and treatment of addictive disorders and their behaviors. The journal publishes broad-spectrum, patient-oriented coverage of all aspects of addiction, directed toward an audience of psychiatrists, clinical psychologists, psychopharmacologists, and primary care practitioners. Original articles help clinicians make more educated, effective decisions regarding optimal patient management and care. In-depth reviews examine current understanding, diagnosis, and treatment of addiction disorders.